Tempus Labs IPO
NASDAQ: TEM
Tempus Labs completed their IPO on June 14, 2024. Now that Tempus Labs is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.
Tempus Labs is a health technology company that leverages artificial intelligence to provide precision medicine solutions across various medical fields. Their platform integrates clinical and molecular data to support diagnostics and personalized treatment plans, particularly in oncology, cardiology, radiology, and psychiatry.
Sign up for SecondMarket® to invest in or sell private companies like Tempus Labs before their IPO.
Buy + SellSee Tempus Labs Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Tempus Labs Stock Valuation + Share Prices
View real-time Tape D® data on Tempus Labs stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Tempus Labs Management Team - Prior to IPO
-
Board Member
Peter Barris
-
Founder, CEO
Eric Lefkofsky
-
Board Member
Ted Leonsis
-
Board Member
Eric Belcher
-
Board Member
Robert Ghenchev
-
Board Member
Wayne Frederick
-
Board Member
Nadja West
-
Board Member
Jennifer A. Doudna
-
Chief Commercial Officer
Terron Bruner
-
CTO
Shane Colley
-
Board Member
Scott Gottlieb
-
COO
Ryan Fukushima
Learn More About Tempus Labs Stock
Buy Tempus Labs Stock
01Tempus Labs became publicly traded following its IPO on June 14, 2024, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: TEM. Before the IPO, Tempus Labs stock was privately held and available only through private market transactions.
If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.
Sell Tempus Labs Stock
02Following its IPO on June 14, 2024, Tempus Labs shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.
If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.
Tempus Labs Stock Price
03Following the IPO, Tempus Labs stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching Tempus Labs’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.
Tempus Labs Stock Ticker Symbol
04Following its IPO on June 14, 2024, Tempus Labs stock now trades on public markets under the ticker symbol NASDAQ: TEM. You can view real-time stock information through widely used financial data platforms.
Criteria to Sell Tempus Labs Stock
05Following the Tempus Labs IPO, public shares can be sold through any brokerage.
Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Tempus Labs Stock
06Following Tempus Labs’s initial public offering on June 14, 2024, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying Tempus Labs stock can do so through their preferred broker, just as they would with any other publicly traded security.
Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Tempus Labs Stock Settlement
07Since Tempus Labs is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.
Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Tempus Labs IPO
08Tempus Labs completed its IPO on June 14, 2024, and is now publicly available through major financial sources.
Sign up for SecondMarket® to invest in or sell private companies like Tempus Labs before their IPO.
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.